Praveg Limited
NSE: PRAVEGMarket Closed • NSE
Day range
52 week range
Praveg Limited closed at INR231.56 (+0.45%) on volume 0.56x its 20-day average, trading 17.59% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved -160% QoQ
2026-09-18
DIVIDEND Announced
Dividend - Re 0.50 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.36x
High Cash Flow Conversion: CFO/PAT averaged 1.72x over last 3 years
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Pharmaceuticals: Major.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 18 Sept 2026 | Dividend | ₹0.50 / share | — | 18 Sept 2026 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Kwality Pharmaceuticals LimitedKPL Open analysis | ₹3,656.36 | 43.57 | 0.00% | ₹162.00 | ₹26.00 | +45.95% | +116.67% |
 Fermenta Biotech LimitedFERMENTA Open analysis | ₹1,393.40 | 23.46 | 0.77% | ₹96.16 | ₹7.68 | — | — |
Praveg LimitedPRAVEG Current stock | ₹605.31 | — | 22.00% | ₹46.00 | -₹13.00 | +17.95% | -116.67% |
Incorporated in 2016 after the merger of Praveg Communications Limited with Sword and Shield Pharma limited; Praveg Communications (India) Limited is an advertising company with core competence in Exhibition and Event Management. The company is also engaged into providing services to the Hospitality sector, Publications and Real Estate marketing. The company has set up its branches nationally and internationally.
IndiaHealth Technology
Is Praveg Limited Shariah compliant?
Praveg Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (28.08%) complies with AAOIFI threshold (≤ 33%).
What is Praveg Limited's current valuation relative to peers?
Praveg Limited trades at a P/E of N/A compared to the sector median of 33.5x, and a Price-to-Book of 1.4x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.36x and a Net Debt to EBITDA ratio of 2.93x. Interest coverage is 4.1x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at 39.9% while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.